Industry Outlook

Kidney Stones Management market accounted for USD 2.62 Billion in 2024 and is expected to reach USD 4.7 Billion by 2035, growing at a CAGR of around 5.6% between 2025 and 2035. The kidney stone management market is growing due to the rising preference for minimally invasive surgeries. These surgeries have minimum complications, and this market involves various treatments, diagnostic methods, and medical devices to remove the stones. The recent trend of this market has shifted towards robotic-assisted surgeries, which helps to get faster recovery. The rising innovations in surgical procedures and technology help to drive market growth. Kidney stones have a high recurrence rate, and most patients experience it multiple times in their lifetime. The kidney stone management market is dynamic and continuously focuses on improving patient care and giving innovative outcomes.

Report Scope:

Market Dynamics

The prevalence and frequent recurrence of kidney stones globally.

The global prevalence and frequent recurrence of kidney stones have a high impact on the kidney stone management market. Furthermore, the increasing recurrence of kidney stones leads to a higher demand for personalized therapies. For instance, the prevalence of renal stones in India is around 12% while recurrence rates of symptomatic stones are high at more than 50% within 5 years of a first episode. This drives the demand for advanced techniques and effective treatments. Industries are shifting towards minimally invasive procedures, which include robotic-assisted surgeries and advanced laser technologies. The growing demand for personalized therapies and precision diagnostics helps in market expansion.

Adverse effects associated with shock wave lithotripsy are likely to hinder market growth.

Kidney stone incidences are increasing, but some of the factors limit its adoption such as severe pain after the procedure, bleeding around the kidney, and blockage in urine due to broken stones hinder the market growth. The lithotripsy may cause a rise in blood pressure and sometimes stone recurrence. Additionally, technological advancements such as percutaneous nephrolithotomy and ureteroscopy may cause fewer side effects. The procedure's high cost and the stone's recurrence adversely impact patient satisfaction

The growing use of robotic-assisted surgery for removing kidney stones

The use of robotic-assisted surgery is increasing. Robotic procedures have been very instrumental in eliminating kidney stones without undergoing any complex procedures. Additionally, this helps to improve the patient's satisfaction. Robotic surgeries are mostly used with people who are born with kidney drainage problems. The robotic-assisted surgery provides the doctor with a wide range of motion and the capacity to make the precise incision. The increasing patient preference for robotic surgeries drives their demand in the kidney stone management market.

Industry Experts Opinion

“Kidney stones can be life-altering – some people place their lives on hold and they worry about a potential kidney stone attack, which can be unexpected. It’s common for people who experience kidney stones to visit the emergency room dozens of times over the course of their lives with a kidney stone attack.”

• Monica Farcas, a surgeon-investigator at St. Michael’s Hospital, Unity Health Toronto, Assistant professor of urology in the University of Toronto’s Temerty Faculty of Medicine

"Kidney stones are a benign condition, but one that can be extraordinarily painful and persistent, often more burdensome than some malignant diseases. The biggest challenge? They keep coming back. Patients often arrive with severe symptoms, and by the time they receive care, the situation can be dire, leading to immense physical and mental suffering,”

• Cho Sung-yong, Professor, Seoul National University Hospital

Segment Analysis

The Global Kidney Stone Management Market is segmented based on Type, Diagnostic, Treatment, Stone size, and Region.

Based on the type, the Kidney Stone Management has been classified into Calcium Oxalate, Calcium Phosphate, Uric Acid, and Struvite. Calcium Oxalate segment dominates the overall market. When the calcium combines with the oxalate in the urine the crystals are formed, Shock Wave Lithotripsy treatment is used for large stones of calcium oxalate, and small-size stones are treated with diuretics.

Based on the treatment, the kidney stone management market has been classified into Lithotripsy, Percutaneous Nephrolithotomy (PCNL), and Ureteroscopy. The kidney stone market is dominated by lithotripsy. Lithotripsy is mostly used for kidney stone removal. Mainly extracorporeal shock wave lithotripsy therapy is used. The stones are broken down into smaller fragments with the help of the shock wave, and then stones are easily passed through the urinary tract. Lithotripsy is a non-invasive treatment.

Regional Analysis

North America is the largest market for kidney stone management. United States particularly exhibits high market growth due to the advanced technologies and high awareness among people. Methods like Lithotripsy and PCNL are widely used in this region. The prevalence of kidney stones is high in this market, which drives the need for innovative treatments. The North American market has benefited from strong technologies and high healthcare spending.

The second largest kidney stone management is in Europe. The European countries are adopting minimally invasive surgical procedures. This procedure helps to improve the accuracy of the treatments. The kidney stone incidence in Europe is increasing due to increased obesity and dietary habits.

Competitive Landscape

The kidney stone management market is very competitive. This market includes various treatment options affecting the market growth. Lithotripsy, percutaneous nephrolithotomy (PCNL), and ureteroscopy methods are available in the market for kidney stone removal, each method has different advantages, and this depends on the stone size. There are market players like Boston Scientific Corporation, Cook Medical, Olympus Corporation, and Medtronic PLC, and these players are continuously focusing on launching and developing new technologies in the market that help to improve the efficiency and the safety of their devices. In April 2024, Cook Medical debuted the new Ascend single-use flexible ureteroscope in the United States and Canada. With a greater variety of products, this development is predicted to boost its regional presence.

Kidney Stones Management Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

•  In February 2024, the LithoGold EM100, an improved extracorporeal shockwave lithotripsy (ESWL) device, was introduced by DirexGroup. The purpose of this product is to enhance kidney stone fragmentation efficacy and patient comfort.
• In February 2023, Boston Scientific Corporation's new digital flexible ureteroscope system, LithoVue Elite, was approved by the FDA. With this launch, the company was able to increase the variety of kidney stone management products it offers while also broadening its customer base.

Report Coverage:

By Type

• Calcium Oxalate
• Calcium Phosphate
• Uric Acid
• Struvite

By Diagnostic

• Abdominal x-ray
• Computed tomography
• Ultrasound
• Abdominal MRI
• Intravenous pyelography
• Optical Coherence Tomography (OCT)
• Others

By Treatment

• Lithotripsy
• Percutaneous nephrolithotomy (PCNL)
• Ureteroscopy
• Others

By Stone Size

• Small Stones (Less than 5mm)
• Medium Stones (5mm to 10mm)
• Large Stones (More than 10mm)

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Boston Scientific Corporation
• Olympus Corporation
• Cook Medical
• Medtronic PLC
• Stryker Corporation
• Lumenis Be Ltd
• Karl Storz SE & Co. KG
• Dornier MedTech GmbH
• Storz Medical AG
• Richard Wolf GmbH
• Terumo Corporation
• Electro Medical Systems
• Blue Neem Medical Devices Pvt Ltd
• Devon Innovations Private Limited
• Rigicon Inc.

Frequently Asked Questions (FAQs)